KR102575312B1 - 망막 색소 상피 세포를 보호하기 위한 노르빅신 함유 조성물 - Google Patents

망막 색소 상피 세포를 보호하기 위한 노르빅신 함유 조성물 Download PDF

Info

Publication number
KR102575312B1
KR102575312B1 KR1020177034255A KR20177034255A KR102575312B1 KR 102575312 B1 KR102575312 B1 KR 102575312B1 KR 1020177034255 A KR1020177034255 A KR 1020177034255A KR 20177034255 A KR20177034255 A KR 20177034255A KR 102575312 B1 KR102575312 B1 KR 102575312B1
Authority
KR
South Korea
Prior art keywords
norbixin
weight
extract
bixin
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177034255A
Other languages
English (en)
Korean (ko)
Other versions
KR20180011777A (ko
Inventor
레네 라퐁
스타니슬라스 베일렛
조제-알랭 사헬
발레리 퐁테인
피에르-폴 엘레나
Original Assignee
바이오파이티스
유니베르시테 피에르 에 마리에 쿠리에 (파리 6)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오파이티스, 유니베르시테 피에르 에 마리에 쿠리에 (파리 6) filed Critical 바이오파이티스
Publication of KR20180011777A publication Critical patent/KR20180011777A/ko
Application granted granted Critical
Publication of KR102575312B1 publication Critical patent/KR102575312B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
KR1020177034255A 2015-04-30 2016-04-28 망막 색소 상피 세포를 보호하기 위한 노르빅신 함유 조성물 Active KR102575312B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1553957 2015-04-30
FR1553957A FR3035589B1 (fr) 2015-04-30 2015-04-30 Composition pour la protection des cellules de l'epithelium pigmentaire retinien
PCT/FR2016/051001 WO2016174360A1 (fr) 2015-04-30 2016-04-28 Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien

Publications (2)

Publication Number Publication Date
KR20180011777A KR20180011777A (ko) 2018-02-02
KR102575312B1 true KR102575312B1 (ko) 2023-09-06

Family

ID=53758384

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177034255A Active KR102575312B1 (ko) 2015-04-30 2016-04-28 망막 색소 상피 세포를 보호하기 위한 노르빅신 함유 조성물

Country Status (15)

Country Link
US (1) US10314804B2 (enExample)
EP (1) EP3288551B1 (enExample)
JP (1) JP6660401B2 (enExample)
KR (1) KR102575312B1 (enExample)
CN (1) CN107708685B (enExample)
AU (1) AU2016256637A1 (enExample)
BR (1) BR112017023264A2 (enExample)
CA (1) CA2984405C (enExample)
ES (1) ES2752061T3 (enExample)
FR (1) FR3035589B1 (enExample)
IL (1) IL255276A0 (enExample)
MX (1) MX376021B (enExample)
PL (1) PL3288551T3 (enExample)
RU (1) RU2715889C2 (enExample)
WO (1) WO2016174360A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CA3098868A1 (en) 2018-05-03 2019-11-07 L.E.A.F. Holdings Group Llc Carotenoid compositions and uses thereof
KR20200134935A (ko) 2019-05-24 2020-12-02 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 약학 조성물
EP4054637A4 (en) * 2019-11-06 2023-12-20 L.E.A.F Holdings Group LLC CAROTINOID COMPOSITIONS AND USES THEREOF
FR3105790B1 (fr) * 2019-12-26 2022-01-14 Biophytis Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires
KR20210008884A (ko) 2021-01-08 2021-01-25 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 조성물 및 기능성 식품 조성물
TWI894483B (zh) * 2022-08-24 2025-08-21 鼎赫生物科技股份有限公司 一種組合物用於治療眼睛疾病之醫藥品用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005110375A1 (en) 2004-05-08 2005-11-24 Paul Edward L Jr Nutritional supplement for treatment of ocular diseases
JP2010285364A (ja) 2009-06-10 2010-12-24 Riken Vitamin Co Ltd 一重項酸素消去剤
US20120149776A1 (en) 2009-06-25 2012-06-14 Stanislas Veillet Preparation for sun protection
US20140322371A1 (en) 2011-05-13 2014-10-30 Stanislas Veillet Bixa orellana composition for treating macular degeneration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1154172A (fr) 1955-07-05 1958-04-03 Rollei Werke Franke Heidecke étui de protection pour appareils photographiques
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
CA2528718A1 (en) * 2003-06-20 2004-12-29 Alcon, Inc. Treatment of amd with combination of ingredients
EP1814540A2 (en) * 2004-11-16 2007-08-08 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
JP2008179632A (ja) * 2006-12-29 2008-08-07 Fuji Chem Ind Co Ltd 抗酸化剤
JP2012097003A (ja) * 2010-10-29 2012-05-24 Gifu City ビキシン誘導体及び細胞保護剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005110375A1 (en) 2004-05-08 2005-11-24 Paul Edward L Jr Nutritional supplement for treatment of ocular diseases
JP2010285364A (ja) 2009-06-10 2010-12-24 Riken Vitamin Co Ltd 一重項酸素消去剤
US20120149776A1 (en) 2009-06-25 2012-06-14 Stanislas Veillet Preparation for sun protection
US20140322371A1 (en) 2011-05-13 2014-10-30 Stanislas Veillet Bixa orellana composition for treating macular degeneration

Also Published As

Publication number Publication date
CA2984405C (fr) 2024-01-23
IL255276A0 (en) 2017-12-31
ES2752061T3 (es) 2020-04-02
PL3288551T3 (pl) 2020-04-30
CA2984405A1 (fr) 2016-11-03
JP6660401B2 (ja) 2020-03-11
FR3035589A1 (fr) 2016-11-04
JP2018518460A (ja) 2018-07-12
BR112017023264A2 (pt) 2018-08-07
RU2017141462A (ru) 2019-05-31
US20180289651A1 (en) 2018-10-11
MX2017013918A (es) 2018-04-24
AU2016256637A1 (en) 2017-12-14
EP3288551A1 (fr) 2018-03-07
US10314804B2 (en) 2019-06-11
CN107708685B (zh) 2021-09-21
RU2715889C2 (ru) 2020-03-04
EP3288551B1 (fr) 2019-07-31
WO2016174360A9 (fr) 2017-11-16
RU2017141462A3 (enExample) 2019-09-12
CN107708685A (zh) 2018-02-16
FR3035589B1 (fr) 2019-12-13
WO2016174360A1 (fr) 2016-11-03
KR20180011777A (ko) 2018-02-02
MX376021B (es) 2025-03-07

Similar Documents

Publication Publication Date Title
KR102575312B1 (ko) 망막 색소 상피 세포를 보호하기 위한 노르빅신 함유 조성물
KR101660195B1 (ko) 크릴 오일과 반응한 아스타잔틴 조성물 및 관련 방법
KR20160140859A (ko) 당뇨성 안질환에 대한 친지질성 영양소의 효과
JP7324263B2 (ja) キサントフィルとヒシ属植物の加工物を含有する組成物
HK1211836A1 (en) Neuroprotective effect of carotenoids in brain
JP7530950B2 (ja) キサントフィルとヒシ属植物の加工物を含有する組成物
Akram et al. β-Carotene: beyond provitamin A
Zhao et al. Advances in research on natural distribution, biosynthesis, detection, bioactivity, and application of lutein
JP5893438B2 (ja) 網膜症の予防又は改善剤
KR20150137088A (ko) 뇌에서 카로티노이드의 신경보호 효과

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000